Author

Cynthia Naret

Observed names: C Naret, C. L. Naret, C. Naret

Institution: Penn State Cancer Institute

Observed institutions: Hôpital Necker-Enfants Malades, National Institutes of Health, Mayo Clinic, Inserm, University of Pittsburgh, University Hospitals of Cleveland, Bristol-Myers Squibb (United States), Assistance Publique – Hôpitaux de Paris, University Hospitals Cleveland Medical Center, UPMC Hillman Cancer Center, Scottsdale Research Institute (United States), National Cancer Institute, Hôpital Saint-Louis, Case Comprehensive Cancer Center, Penn State Cancer Institute

OpenAlex ID: A5031046019

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid Tumors

2010 · Ramesh K. Ramanathan, Merrill J. Egorin, et al. · Journal of Clinical Oncology · 87

Phase I and Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients with Refractory Advanced Cancers

2007 · Ramesh K. Ramanathan, Merrill J. Egorin, et al. · Clinical Cancer Research · 87

Dual Inhibition of the Epidermal Growth Factor Receptor with Cetuximab, an IgG1 Monoclonal Antibody, and Gefitinib, A Tyrosine Kinase Inhibitor, in Patients with Refractory Non-small Cell Lung Cancer (NSCLC): A Phase I Study

2008 · Suresh Ramalingam, Judy Forster, et al. · Journal of Thoracic Oncology · 51

Role of secondary hyperparathyroidism in spontaneous rupture of the quadriceps tendon complicating chronic renal failure

2005 · M. Thaunat, P. Gaudin, et al. · Lara D. Veeken · 34

Skin disorders and vitamin A metabolism disturbances in chronic dialysis patients: the role of zinc, retinol-binding protein, retinol and retinoic acid

1984 · E. Delacoux, Th. Evstigneeff, et al. · Clinica Chimica Acta · 16

Kinetics of Erythropoiesis in Dialysis Patients Receiving Recombinant Erythropoietin Treatment

1989 · Y. Najean, A. Moynot, et al. · Nephrology Dialysis Transplantation · 12

Total blockade of the epidermal growth factor receptor with the combination of cetuximab and gefitinib: A phase I study for patients with recurrent non-small cell lung cancer (NSCLC)

2006 · C. L. Naret, S. Ramalingam, et al. · Journal of Clinical Oncology · 11

Utilization of erythropoietin in the treatment of the anemia due to chronic renal failure.

1989 · T Drüeke, B Zins, et al. · PubMed · 7

Accumulation of 5 alpha-reduced androgen glucosiduronates associated with impaired removal in young male hemodialysis patients

1995 · P Boudou, C Naret, et al. · The Journal of Clinical Endocrinology & Metabolism · 3

Analysis of renal function in patients entered onto CTEP-sponsored phase I studies since 1979

2007 · W. M. McHayleh, R. Sehgal, et al. · Journal of Clinical Oncology · 2

Phase I, pharmacokinetic (PK), & pharmacodynamic (PD) study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, (17DMAG, NSC 707545) in patients with advanced solid tumors

2006 · M. J. Egorin, C. P. Belani, et al. · Journal of Clinical Oncology · 2

Phase I trial of motexafin gadolinium (MGd) and docetaxel (D) chemotherapy in the treatment of advanced solid tumors

2005 · D. P. Petro, M. J. Egorin, et al. · Journal of Clinical Oncology · 1

[Results of hormonal studies in 23 adolescents with renal failure treated by chronic dialysis].

1988 · P Garnier, C Naret, et al. · PubMed · 1

Successful reduction of hypertriglyceridaemia (H.T.G.) by ambulatory dietary manipulation in young dialysed patients.

1978 · C Ciancioni, F Dairou, et al. · PubMed · 1

Cancer Treatment Consent Forms Are Still Difficult to Read

2013 · H. Wagner, H. Mackley, et al. · International Journal of Radiation Oncology*Biology*Physics

Erythropoietin and chronic renal failure.

1989 · T Drüeke, B Zins, et al. · PubMed

Continuous ambulatory EEG monitoring following desferrioxamine (DFO) i.v. infusion.

1985 · J L Poignet, M F Monge, et al. · PubMed

Works count: 17

Citation count: 315

H-index: 7

I10-index: 7